You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the APLENZIN (bupropion hydrobromide) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Sales Trends for APLENZIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Sales Revenue Trends for APLENZIN
Drug Units Sold Trends for APLENZIN

Annual Sales Revenues and Units Sold for APLENZIN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
APLENZIN ⤷  Sign Up ⤷  Sign Up 2021
APLENZIN ⤷  Sign Up ⤷  Sign Up 2020
APLENZIN ⤷  Sign Up ⤷  Sign Up 2019
APLENZIN ⤷  Sign Up ⤷  Sign Up 2018
APLENZIN ⤷  Sign Up ⤷  Sign Up 2017
APLENZIN ⤷  Sign Up ⤷  Sign Up 2016
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.